High Frequency Chest Wall Oscillation Devices - MEDICAID - LOUISIANA

This policy covers high‑frequency chest wall oscillation devices for members with cystic fibrosis, neuromuscular disorders, bronchiectasis (requiring CT confirmation plus either daily productive cough for ≥6 continuous months or >2 antibiotic‑treated exacerbations/year), or those with well‑documented failure of standard secretion‑mobilization therapies. Coverage requires age‑appropriate trials of chest physical therapy and a flutter device at least twice daily, a pattern of at least annual hospitalizations, significant clinical deterioration, management by a pulmonologist, and copies of two pulmonary tests showing improvement with the vest; if these and the bronchiectasis imaging/symptom criteria are not met the device is not supported.

"4."

Sign up to see full coverage criteria, indications, and limitations.